Green Cross teams up with IPK on screening of new drugs

Green Cross Corp. said Tuesday that it has entered into a collaborative agreement with Institut Pasteur Korea (IPK), centered on the establishment of a compound library, for the identification and development of safe, effective and affordable new treatments for patients suffering from cancer or rare disease.

The agreement brings together the knowledge and capabilities of each organization, w...